Suchergebnisse - "Shen, Kunwei"

PubPharm (313)

1

Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer : final analysis of the randomized phase III PEONY trial

enthalten in: Nature communications | 2024

von Huang, L. | Pang, D. | Yang, H. | +21

2

Anti-HER2 therapy response assessment for guiding treatment (de-)escalation in early HER2-positive breast cancer using a novel deep learning radiomics model

enthalten in: European radiology | 2024

von Tong, Y. | Hu, Z. | Wang, H. | +9

3

Feasibility of a mobile health app-based self-management program for Chinese patients with breast cancer receiving chemotherapy : A randomized controlled pilot study

enthalten in: Digital health | 2024

von Shi, N. | Ching Wong, A. | Yuet Wong, F. | +8

4

Decitabine induces IRF7-mediated immune responses in p53-mutated triple-negative breast cancer : a clinical and translational study

enthalten in: Frontiers of medicine | 2023

von Wang, H. | Wang, Z. | Wang, Z. | +13

5

The anti-breast cancer potential of indole/isatin hybrids

enthalten in: Archiv der Pharmazie | 2023

von Wang, R. | Huang, R. | Yuan, Y. | +2

6

Safety analysis of immediate breast reconstruction with a deep inferior epigastric perforator (DIEP) flap in the post-COVID-19 era : a comparison between pre- and post-pandemic cohorts

enthalten in: Gland surgery | 2023

von Gao, W. | Lu, Y. | Huang, O. | +7

7

Tumor size is associated with adjuvant chemotherapy benefit in T1N0M0 triple-negative breast cancer : a multicenter and propensity score matched analysis

enthalten in: Gland surgery | 2023

von Wu, C. | Huang, O. | Wu, J. | +3

8

Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy

enthalten in: Cell death & disease | 2023

von Huang, R. | Wang, Z. | Hong, J. | +7

9

Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment : a multicenter analysis of 2489 cases

enthalten in: British journal of cancer | 2023

von Zhu, S. | Lu, Y. | Fei, X. | +2

10

Clinical characteristics, tumor-infiltrating lymphocytes, and prognosis in HER2-low breast cancer : A comparison study with HER2-zero and HER2-positive disease

enthalten in: Cancer medicine | 2023

von Lu, Y. | Tong, Y. | Fei, X. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]